WallStreetZenWallStreetZen

NASDAQ: NRIX
Nurix Therapeutics Inc Stock Ownership - Who owns Nurix Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Nurix Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christine RingChief Legal Officer2026-06-028,148$16.60
$135.25kSell
Christine RingChief Legal Officer2026-06-023,422$1.86
$6.36kBuy
Houte Hans VanChief Financial Officer2026-05-05582$17.18
$10.00kSell
Houte Hans VanChief Financial Officer2026-05-0513,473$16.58
$223.33kSell
Christine RingChief Legal Officer2026-05-048,148$16.96
$138.21kSell
Christine RingChief Legal Officer2026-05-015,394$16.76
$90.41kSell
Christine RingChief Legal Officer2026-04-303,214$16.65
$53.50kSell
Gwenn HansenChief Scientific Officer2026-04-303,214$16.65
$53.50kSell
Houte Hans VanChief Financial Officer2026-04-302,388$16.65
$39.75kSell
Christine RingChief Legal Officer2026-04-028,148$15.24
$124.15kSell

1 of 4

NRIX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NRIX insiders and whales buy or sell their stock.

NRIX Shareholders

What type of owners hold Nurix Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc8.63%8,925,642$156.65MInstitution
Redmile Group LLC7.48%7,732,808$135.71MInstitution
Vestal Point Capital LP6.29%6,500,000$114.08MInstitution
Deep Track Capital LP6.14%6,345,244$111.36MInstitution
Fmr LLC5.36%5,541,271$97.25MInstitution
State Street Corp4.97%5,141,195$90.23MInstitution
Morgan Stanley4.77%4,931,999$86.56MInstitution
Baker Bros Advisors LP4.51%4,658,556$81.76MInstitution
Vanguard Capital Management LLC4.28%4,427,112$77.70MInstitution
General Atlantic LP3.97%4,101,865$71.99MInstitution

1 of 3

NRIX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NRIX93.25%6.75%Net SellingNet Selling
RAPP77.56%22.44%Net SellingNet Selling
TSHA89.33%10.67%Net SellingNet Selling
SRPT77.22%22.78%Net Selling
MESO0.26%19.20%Net BuyingNet Buying
View Top Biotech Stocks

Nurix Therapeutics Stock Ownership FAQ

Who owns Nurix Therapeutics?

Nurix Therapeutics (NASDAQ: NRIX) is owned by 113.17% institutional shareholders, 8.20% Nurix Therapeutics insiders, and 0.00% retail investors. Third Rock Ventures III LP is the largest individual Nurix Therapeutics shareholder, owning 3.51M shares representing 3.39% of the company. Third Rock Ventures III LP's Nurix Therapeutics shares are currently valued at $61.59M.

If you're new to stock investing, here's how to buy Nurix Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.